Sponsor Pipeline

Yunhe Pharmaceutical (Tianjin) Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06922929 A Multicenter, Open-label, Prospective Phase III Clinical Trial to Evaluate INR101… Prostate Cancer Recurrent Not Yet Recruiting
NCT06922903 Phase III Clinical Trial to Evaluate INR101 Injection for PET/CT Imaging in Patients With… Prostate Cancer Not Yet Recruiting
Phase 1/2
NCT06970119 A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102… Prostate Cancer Recruiting
Disease Areas
Prostate Cancer (3)
Get alerts when Yunhe Pharmaceutical (Tianjin) Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free